STRATEGIC INFLECTION POINTS
DURING CLINICAL DEVELOPMENT
& The VALUE OF SMART PARTNERING
- Managing multiple stakeholder perspectives in translational medicine with transformative therapies
- Innovative study design and operational solutions from first-in-human through proof of concept
- Strategies for early collaboration with regulatory authorities tailored to business objectives
SAVE YOUR SEAT
The Uncommon Conversations in Drug Development Live series, hosted by Worldwide Clinical Trials’ scientific, operational and medical experts, is more than your average networking event. Designed with emerging to midsized biopharma and pharma in mind, it’s an uncommon environment for our peers to collaborate, meet like-minded execs, and gain introductions to those who have successfully faced the same challenges.
DATE & TIME: November 13, 2019 | 12:30 – 16:30
LOCATION: Chateau Margaux, 2 Aharon Eisenberg Rehovot 7629101, Israel
AGENDA: 1-hour moderated panel discussion followed by networking reception
MEET THE SPEAKERS
Angelico Carta, M.D.
President
Worldwide Clinical Trials
Aman Khera
Global Head of Regulatory Strategy
Worldwide Clinical Trials
Giuseppe Rosano M.D., Ph.D.
Member Cardiovascular Working Party
European Medicines Agency
HOW WELL DO YOU KNOW WORLDWIDE CLINICAL TRIALS?
You’ve probably heard about Worldwide’s full-service, award-winning CRO services spanning Bioanalytical, Phase I-IV clinical trial, and Real-World Evidence. And most people know that our therapeutic expertise is focused on Central Nervous System, Cardiovascular and Metabolic, Oncology, Rare Diseases, or General Medicine.
Yet, there might be a few things about Worldwide you don’t know.
We live and breathe to be UNCOMMON, and it all starts with innovation. Every clinical trial is unique and deserves an uncommon, innovative approach deeply rooted in a commitment to operational excellence. That’s why we are creating uncommon events to connect executives with their industry peers to generate ideas, exchange insights and discuss inventive new strategies to overcome clinical trial obstacles. Advancing medicine to improve the lives of patients around the world is our passion, and we believe when you bring together biopharma’s top minds, magic happens.